卵巢高级别浆液性癌患者淋巴结转移评估:双能CT联合形态学参数的增量诊断价值
回顾性纳入39例卵巢高级别浆液性癌患者的141枚淋巴结,评估双能CT参数与形态学参数鉴别转移与非转移淋巴结的价值。形态学模型AUC为0.793,双能CT模型AUC为0.762,两者联合AUC达0.845,显著高于单一模型。双能CT参数为评估淋巴结转移提供增量诊断价值。
要点
- 转移性淋巴结短径、长径及短长径比均显著大于非转移性淋巴结。
- 静脉期双能CT参数中,λHU、VNC、Rho在转移性淋巴结较高,IC、NIC、Zeff、DEI较低。
- 形态学联合双能CT模型AUC为0.845,优于形态学模型0.793和双能CT模型0.762。
核心结论
- 双能CT参数在评估卵巢高级别浆液性癌患者转移性淋巴结方面提供增量诊断价值,形态学与双能CT模型联合较单独形态学模型显著提高诊断效能。
研究设计与样本
- 回顾性研究,纳入2021年10月至2024年5月39例卵巢高级别浆液性癌患者的141枚淋巴结,以病理报告为参考标准,评估5项形态学参数和9项双能CT参数(动脉期和静脉期)。
关键影像表现/征象
- 转移性淋巴结短径9.69±4.06 mm vs 非转移性6.37±1.24 mm(P<0.001),长径13.99±5.36 mm vs 9.61±2.30 mm(P<0.001),短长径比0.70±0.15 vs 0.67±0.12(P=0.023)。
- 静脉期λHU转移性-3.596±1.115 vs 非转移性-4.234±1.077(P=0.001),VNC 24.242±9.867 vs 15.826±11.830(P<0.001),Rho 32.557±8.023 vs 26.936±9.420(P<0.001)。
- 静脉期IC转移性1.872±0.678 vs 非转移性2.404±1.140(P=0.001),NIC 38.309±14.443 vs 47.247±22.270(P=0.005),Zeff 8.513±0.320 vs 8.719±0.360(P=0.001),DEI 0.014±0.006 vs 0.018±0.007(P=0.045)。
诊断标准与关键数值
- 形态学模型鉴别转移与非转移淋巴结的AUC为0.793(95%CI:0.721-0.862)。
- 双能CT模型AUC为0.762(95%CI:0.690-0.825)。
- 形态学与双能CT联合模型AUC为0.845(95%CI:0.780-0.896),显著高于形态学模型(P=0.015)和双能CT模型(P=0.006)。
临床应用与阅片要点
- 阅片时可结合淋巴结短径、长径及短长径比等形态学参数评估转移风险。
- 静脉期双能CT参数(λHU、VNC、Rho、IC、NIC、Zeff、DEI)可为鉴别转移与非转移淋巴结提供补充信息。
- 形态学与双能CT联合模型诊断效能最佳,提示联合评估可能提高术前淋巴结分期准确性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the feasibility of Dual-Energy Computed Tomography (DECT) in distinguishing metastatic from non-metastatic lymph nodes (LNs) in ovarian High-Grade Serous Carcinoma (HGSC), and to assess the incremental diagnostic value of combining DECT with morphologic parameters in differentiating metastatic and non-metastatic LNs.
METHODS: From October 2021 to May 2024, 141 LNs from 39 patients with HGSC who underwent DECT were retrospectively enrolled. LNs were matched with the pathological report. Five morphologic parameters and nine DECT parameters were assessed. DECT parameters were obtained from both the arterial and venous phases, including the attenuation at 40 and 70 keV, slope of the spectral Hounsfield unit curve (λHu), Virtual Non-Contrast (VNC), Iodine Concentration (IC), Normalized Iodine Concentration (NIC), electron density (Rho), effective atomic number (Zeff) and Dual-Energy Index (DEI). Independent-sample Student's t test was used to compare continuous variables, while multivariable binary logistic regression analyses was applied to identify independent predictors for LN metastasis in the morphology, DECT, and combined models. Receiver Operating Characteristic (ROC) analysis was performed to evaluate the diagnostic performance of these three models in differentiating metastatic from non-metastatic LNs.
RESULTS: 86 metastatic LNs and 55 non-metastatic LNs were finally enrolled in our study. The short diameter (S), long diameter (L), and S/L ratio were significantly larger in metastatic LNs compared to non-metastatic LNs (9.69 ± 4.06 vs. 6.37 ± 1.24 mm, P < 0.001; 13.99 ± 5.36 vs.9.61 ± 2.30 mm, P < 0.001; 0.70 ± 0.15 vs. 0.67 ± 0.12, P = 0.023). In the venous phase, λHU, VNC and Rho were significantly higher in metastatic LNs compared to non-metastatic LNs (-3.596 ± 1.115 vs. -4.234 ± 1.077, P = 0.001; 24.242 ± 9.867 vs. 15.826 ± 11.830, P < 0.001; 32.557 ± 8.023 vs. 26.936 ± 9.420, P < 0.001), while IC, NIC, Zeff, DEI were significant lower in metastatic LNs than non-metastatic LNs (1.872 ± 0.678 vs. 2.404 ± 1.140, P = 0.001; 38.309 ± 14.443 vs. 47.247 ± 22.270, P = 0.005; 8.513 ± 0.320 vs. 8.719 ± 0.360, P = 0.001; 0.014 ± 0.006 vs. 0.018 ± 0.007, P = 0.045). The Area Under the Curve (AUC) of morphology model and DECT model were 0.793 (95 %CI: 0.721-0.862) and 0.762(95 %CI: 0.690-0.825), respectively. The combination of the morphology model and DECT model revealed optimal diagnostic performance (AUC = 0.845; 95 %CI: 0.780-0.896), which was significantly higher than that of the individual models (P = 0.015, P = 0.006, respectively).
CONCLUSION: DECT parameters provide incremental diagnostic value in assessing metastatic LNs in patients with HGSC. The combination of the morphology and DECT models significantly improves diagnostic performance compared to the standalone morphology model.
引用
- Zhang A, Shao W, Song J, et al. Assessment of lymph node metastases in patients with ovarian high-grade serous carcinoma: Incremental diagnostic value of dual-energy CT combined with morphologic parameters. Eur J Radiol. 2025. PMID: 40222185. doi:10.1016/j.ejrad.2025.112107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。